L-Milnacipran Hydrochloride API

Name	L-Milnacipran Hydrochloride
Chinese name	盐酸左旋米那普仑
Cas Number	175131-60-9
Source	India
Qualifications	-/-/-/-/-

Levomilnacipran hydrochloride is the fourth 5-HT/NE reuptake inhibitor (SNRIs) approved by the FDA for the market. It was approved by the US FDA in 2009 for the treatment of fibromyalgia (fibromyalgia), and was approved in July 2013. It is a new type of antidepressant, used to treat major-depressive disorder (MDD) in adults. This product is a new type of antidepressant with the effect of inhibiting reuptake of norepinephrine and 5-HT. It can inhibit the reuptake of the above two transmitters in the nerve endings, so that the concentration of the above two transmitters in the synaptic cleft continues Increase, its 1S, 2R enantiomers can effectively improve the social function of patients, can achieve better antidepressant effects, and will not increase the side effects of drugs. Studies have confirmed that L-milnacipran has a significant effect on the core symptoms of depression (lack of interest and lack of energy), which is superior to traditional SSRIs antidepressants, and has a low incidence of adverse reactions and is safe and reliable.

Hot Tags: l-milnacipran hydrochloride api, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Lurasidone Hydrochloride API, Bemeprost API, Itraconazole Hydrochloride API, Bosentan API, Ranolazine API, Tavaborol API

• Previous: Bromfenac Sodium API
• Next: Crotamiton/Universal API